Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Dermatology : EJD|March 11, 2024
Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patientsElisabeth Cohen, Coralie Lheure, Saskia Ingen-Housz-Oro, et al.
Cancers|April 15, 2020
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic MelanomaDavid Balakirouchenane, Sarah Guégan, Chantal Csajka, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitorsLucia Parlati, Mehdi Sakka, Aurelia Retbi, et al.
Journal of Autoimmunity|February 8, 2024
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trialRoberta Lorenzon, Claire Ribet, Fabien Pitoiset, et al.
The Journal of Investigative Dermatology|February 11, 2015
Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human SkinEve Maubec, Cédric Laouénan, Lydia Deschamps, et al.
Autoimmunity Reviews|September 18, 2017
Clinical and pathological significance of cutaneous manifestations in ANCA-associated vasculitidesLaure Frumholtz, Sara Laurent-Roussel, Olivier Aumaître, et al.
Journal of the American Academy of Dermatology|August 25, 2025
Genomic and clinical characterization of anogenital basal cell carcinoma: a retrospective and prospective cohort studyLea Dousset, Andrey A Yurchenko, Johan Chanal, et al.
The Journal of Pathology|October 24, 2025
Genetic landscape of non-UV-induced cutaneous squamous cell carcinomasCarmen Al Youssef, Mansour Alkobtawi, Rémi Safi, et al.
Rheumatology (Oxford, England)|January 23, 2025
Off-label use of biologics in urticarial vasculitis: a European retrospective cohort studyLucas Maisonobe, Anne-Sophie Korganow, Alvise Berti, et al.
Pageof 8